Paperbase

A Bacterial Toxin with Analgesic Properties: Hyperpolarization of DRG Neurons by Mycolactone

Ok-Ryul Song Han-Byul Kim Samuel Jouny Isabelle Ricard Alexandre Vandeputte Nathalie Deboosere Estelle Marion Christophe Queval Pierre Lesport Emmanuel Bourinet Daniel Henrion Seog Oh Guillaume Lebon Guillaume Sandoz Edouard Yeramian Laurent Marsollier Priscille Brodin

Toxins, 2017-7

https://doi.org/10.3390/toxins9070227

Lebon Guillaume

Guillaume Lebon

ORCID: 0000-0003-1162-5148

Direct coupling of detergent purified human mGlu5 receptor to the heterotrimeric G proteins Gq and Gs. 10.1038/s41598-018-22729-4

Human Adenosine A2A Receptor: Molecular Mechanism of Ligand Binding and Activation. 10.3389/fphar.2017.00898

A Bacterial Toxin with Analgesic Properties: Hyperpolarization of DRG Neurons by Mycolactone. 10.3390/toxins9070227

Diverse activation pathways in class A GPCRs converge near the G-protein-coupling region. 10.1038/nature19107

A mutagenesis and screening strategy to generate optimally thermostabilized membrane proteins for structural studies. 10.1038/nprot.2016.088

Molecular Determinants of CGS21680 Binding to the Human Adenosine A2A Receptor. 10.1124/mol.114.097360

Purification and Crystallization of a Thermostabilized Agonist-Bound Conformation of the Human Adenosine A(2A) Receptor. 10.1007/978-1-4939-2914-6_2

Pharmacology and structure of isolated conformations of the adenosine A₂A receptor define ligand efficacy. 10.1124/mol.112.084509

Molecular signatures of G-protein-coupled receptors. 10.1038/nature11896

[G protein-coupled receptors in the spotlight]. 10.1051/medsci/20122810017

Outrunning free radicals in room-temperature macromolecular crystallography. 10.1107/S0907444912012553

Agonist-bound structures of G protein-coupled receptors. 10.1016/j.sbi.2012.03.007

[Structure of the adenosine-bound conformation of the human adenosine A(2A) receptor]. 10.1051/medsci/20112711004

Agonist-bound adenosine A2A receptor structures reveal common features of GPCR activation. 10.1038/nature10136

Thermostabilisation of an agonist-bound conformation of the human adenosine A(2A) receptor. 10.1016/j.jmb.2011.03.075

Pi sampling: a methodical and flexible approach to initial macromolecular crystallization screening. 10.1107/S0907444911008754

Mutagenic mapping suggests a novel binding mode for selective agonists of M1 muscarinic acetylcholine receptors. 10.1124/mol.108.050963

Competition on nitrocellulose-immobilized antibody arrays: from bacterial protein binding assay to protein profiling in breast cancer cells. 10.1074/mcp.m400181-mcp200

Fine-tuning receptor-G protein activation and signaling. 10.1126/science.abc9291

Development and validation of a mass spectrometry binding assay for mGlu5 receptor. 10.1007/s00216-020-02772-9

Piezo1 is required for outflow tract and aortic valve development. 10.1016/j.yjmcc.2020.03.013

Agonists and allosteric modulators promote signaling from different metabotropic glutamate receptor 5 conformations. 10.1016/j.celrep.2021.109648

Priscille Brodin

Brodin Priscille

ORCID: 0000-0003-0991-7344

Email: priscille.brodin@inserm.fr

How can nanoparticles contribute to antituberculosis therapy? 10.1016/j.drudis.2017.01.011

Host-directed therapies offer novel opportunities for the fight against tuberculosis 10.1016/j.drudis.2017.05.005

A Bacterial Toxin with Analgesic Properties: Hyperpolarization of DRG Neurons by Mycolactone 10.3390/toxins9070227

A Bacterial Toxin with Analgesic Properties: Hyperpolarization of DRG Neurons by Mycolactone 10.3390/toxins9070227 10.3390/toxins9070227.

Clofazimine encapsulation in nanoporous silica particles for the oral treatment of antibiotic-resistant Mycobacterium tuberculosis infections 10.2217/nnm-2016-0364

Cyclodextrin-based nanocarriers containing a synergic drug combination: a potential formulation for pulmonary administration of antitubercular drugs 10.1016/j.ijpharm.2017.05.030 10.1016/j.ijpharm.2017.05.030.

Genome-wide, high-content siRNA screening identifies the Alzheimer's genetic risk factor FERMT2 as a major modulator of APP metabolism 10.1007/s00401-016-1652-z

Host-directed therapies offer novel opportunities for the fight against tuberculosis 10.1016/j.drudis.2017.05.005 10.1016/j.drudis.2017.05.005.

Identification of aminopyrimidine-sulfonamides as potent modulators of Wag31-mediated cell elongation in mycobacteria 10.1111/mmi.13535

Impact of pe_ pgrs33 Gene Polymorphisms on Mycobacterium tuberculosis Infection and Pathogenesis 10.3389/fcimb.2017.00137

LppM impact on the colonization of macrophages by Mycobacterium tuberculosis 10.1111/cmi.12619

Phenotypic assays for Mycobacterium tuberculosis infection 10.1002/cyto.a.23129 10.1002/cyto.a.23129.

Reversion of antibiotic resistance in Mycobacterium tuberculosis by spiroisoxazoline SMARt-420 10.1126/science.aag1006

A fragment merging approach towards the development of small molecule inhibitors of Mycobacterium tuberculosis EthR for use as ethionamide boosters 10.1039/c5ob02630j

Khaya grandifoliola C.DC: a potential source of active ingredients against hepatitis C virus in vitro 10.1007/s00705-016-2771-5

Mycobacterium tuberculosis LppM Displays an Original Structure and Domain Composition Linked to a Dual Localization 10.1016/j.str.2016.07.009

Mycolactone The amazing analgesic mycobacterial toxin 10.1051/medsci/20163202007

STAT3 Represses Nitric Oxide Synthesis in Human Macrophages upon Mycobacterium tuberculosis Infection 10.1038/srep29297

2-Carboxyquinoxalines Kill Mycobacterium tuberculosis through Noncovalent Inhibition of DprE1 10.1021/cb5007163

Cytosolic Access of Mycobacterium tuberculosis: Critical Impact of Phagosomal Acidification Control and Demonstration of Occurrence In Vivo 10.1371/journal.ppat.1004650

High content screening in chemical biology: overview and main challenges 10.1051/medsci/20153102016

High-Content Screening Technology Combined with a Human Granuloma Model as a New Approach To Evaluate the Activities of Drugs against Mycobacterium tuberculosis 10.1128/aac.03705-14

Increased protective efficacy of recombinant BCG strains expressing virulence-neutral proteins of the ESX-1 secretion system 10.1016/j.vaccine.2015.03.083

Plant extracts from Cameroonian medicinal plants strongly inhibit hepatitis C virus infection in vitro 10.3389/fmicb.2015.00438

Polyphenols Inhibit Hepatitis C Virus Entry by a New Mechanism of Action 10.1128/jvi.01473-15

Testing chemical and genetic Modulators in Mycobacterium tuberculosis infected cells using phenotypic assays 10.1007/978-1-4939-2450-9_24

A Microscopic Phenotypic Assay for the Quantification of Intracellular Mycobacteria Adapted for High-throughput/High-content Screening 10.3791/51114

Ligand Efficiency Driven Design of New Inhibitors of Mycobacterium tuberculosis Transcriptional Repressor EthR Using Fragment Growing, Merging, and Linking Approaches 10.1021/jm500422b

Mycobacterial Toxin Induces Analgesia in Buruli Ulcer by Targeting the Angiotensin Pathways 10.1016/j.cell.2014.04.040

Potent antiviral activity of Solanum rantonnetii and the isolated compounds against hepatitis C virus in vitro 10.1016/j.jff.2014.09.022

A novel specific edge effect correction method for RNA interference screenings 10.1093/bioinformatics/btr648

Discovery of Novel N-Phenylphenoxyacetamide Derivatives as EthR Inhibitors and Ethionamide Boosters by Combining High-Throughput Screening and Synthesis 10.1021/jm3003779

Ethionamide Boosters. 2. Combining Bioisosteric Replacement and Structure-Based Drug Design To Solve Pharmacokinetic Issues in a Series of Potent 1,2,4-Oxadiazole EthR Inhibitors 10.1021/jm200825u

The Balance of Apoptotic and Necrotic Cell Death in Mycobacterium tuberculosis Infected Macrophages Is Not Dependent on Bacterial Virulence 10.1371/journal.pone.0047573

Analogous Mechanisms of Resistance to Benzothiazinones and Dinitrobenzamides in Mycobacterium smegmatis 10.1371/journal.pone.0026675

Ethionamide Boosters: Synthesis, Biological Activity, and Structure-Activity Relationships of a Series of 1,2,4-Oxadiazole EthR Inhibitors 10.1021/jm200076a

High-content screening in infectious diseases 10.1016/j.cbpa.2011.05.023

Functional characterization of the Mycobacterium tuberculosis serine/threonine kinase PknJ 10.1099/mic.0.038133-0

High Content Phenotypic Cell-Based Visual Screen Identifies Mycobacterium tuberculosis Acyltrehalose-Containing Glycolipids Involved in Phagosome Remodeling 10.1371/journal.ppat.1001100

High-content imaging of Mycobacterium tuberculosis-infected macrophages: an in vitro model for tuberculosis drug discovery 10.4155/fmc.10.223

Long-circulating DNA lipid nanocapsules as new vector for passive tumor targeting 10.1016/j.biomaterials.2009.09.044

Automated High-Throughput siRNA Transfection in Raw 264.7 Macrophages: A Case Study for Optimization Procedure 10.1177/1087057108328762

Benzothiazinones Kill Mycobacterium tuberculosis by Blocking Arabinan Synthesis 10.1126/science.1171583

High Content Screening Identifies Decaprenyl-Phosphoribose 2 ' Epimerase as a Target for Intracellular Antimycobacterial Inhibitors 10.1371/journal.ppat.1000645

Systematic Genetic Nomenclature for Type VII Secretion Systems 10.1371/journal.ppat.1000507

Control of M-tuberculosis ESAT-6 secretion and specific T cell recognition by PhoP 10.1371/journal.ppat.0040033

Aquatic insects and transmission of Mycobacterium ulcerans 10.1051/medsci/20072367572

ESAT-6 from Mycobacterium tuberculosis dissociates from its putative chaperone CFP-10 under acidic conditions and exhibits membrane-lysing activity 10.1128/jb.00469-07

Impact of Mycobacterium ulcerans biofilm on transmissibility to ecological niches and Buruli ulcer pathogenesis 10.1371/journal.ppat.0030062

Protection against mycobacterium ulcerans lesion development by exposure to aquatic insect saliva 10.1371/journal.pmed.0040064

Support vector machines for automatic detection of tuberculosis bacteria in confocal microscopy images 10.1109/isbi.2007.356794

Synthesis and antimycobacterial evaluation of benzofurobenzopyran analogues 10.1016/j.bmc.2006.12.009

An increase in antimycobacterial Th1-cell responses by prime-boost protocols of immunization does not enhance protection against tuberculosis 10.1128/iai.74.4.2128-2137.2006

Benzofuro 3,2-f 1 benzopyrans: A new class of antitubercular agents 10.1016/j.bmc.2006.03.033

Dissection of ESAT-6 system 1 of Mycobacterium tuberculosis and impact on immunogenicity and virulence 10.1128/iai.74.1.88-98.2006

High frequency of CD4(+) T cells specific for the TB10.4 protein correlates with protection against Mycobacterium tuberculosis infection 10.1128/iai.02086-05

Inactivation of Rv2525c, a substrate of the twin arginine translocation (Tat) system of Mycobacterium tuberculosis, increases beta-lactam susceptibility and virulence 10.1128/jb.00631-06

Evaluation of vaccines in the EU TB vaccine cluster using a guinea pig aerosol infection model of tuberculosis 10.1016/j.tube.2004.09.009

Functional analysis of early secreted antigenic target-6, the dominant T-cell antigen of Mycobacterium tuberculosis, reveals key residues involved in secretion, complex formation, virulence, and immunogenicity 10.1074/jbc.M503515200

Immunogenic membrane-associated proteins of Mycobacterium tuberculosis revealed by proteomics 10.1099/mic.0.27799-0

Proteomic identification of M. tuberculosis protein kinase substrates: PknB recruits GarA, a FHA domain-containing protein, through activation loop-mediated interactions 10.1016/j.jmb.2005.05.049

Tuberculosis: from genome to vaccine 10.1586/14760584.4.4.541

Cell envelope protein PPE68 contributes to Mycobacterium tuberculosis RDI immunogenicity independently of a 10-kilodalton culture filtrate protein and ESAT-6 10.1128/iai.72.4.2170-2176.2004

Enhanced protection against tuberculosis by vaccination with recombinant Mycobacterium microti vaccine that induces T cell immunity against region of difference 1 antigens 10.1086/421468

ESAT-6 proteins: protective antigens and virulence factors? 10.1016/j.tim.2004.09.007

Macro-array and bioinformatic analyses reveal mycobacterial 'core' genes, variation in the ESAT-6 gene family and new phylogenetic markers for the Mycobacterium tuberculosis complex 10.1099/mic.0.26662-0

CD8(+)-T-cell responses of mycobacterium-infected mice to a newly identified major histocompatibility complex class I-restricted epitope shared by proteins of the ESAT-6 family 10.1128/iai.71.12.7173-7177.2003

Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis 10.1038/nm859

A new evolutionary scenario for the Mycobacterium tuberculosis complex 10.1073/pnas.052548299

Bacterial artificial chromosome-based comparative genomic analysis identifies Mycobacterium microti as a natural ESAT-6 deletion mutant 10.1128/iai.70.10.5568-5578.2002

Disruption of HIV-1 integrase-DNA complexes by short 6-oxocytosine-containing oligonucleotides 10.1021/bi015732y

Loss of RD1 contributed to the attenuation of the live tuberculosis vaccines Mycobacterium bovis BCG and Mycobacterium microti 10.1046/j.1365-2958.2002.03237.x

6-Oxocytidine containing oligonucleotides inhibit the HIV-1 integrase in vitro 10.1081/ncn-100002322

Determinants of Mg2+-dependent activities of recombinant human immunodeficiency virus type 1 integrase 10.1021/bi000398b

Inhibition of the human immunodeficiency virus type 1 DNA integration by modified oligonucleotides 10.1023/a:1026631910681

Branched oligonucleotide-intercalator conjugate forming a parallel stranded structure inhibits HIV-1 integrase 10.1016/s0014-5793(99)01350-2

Inhibition of HIV-1 integration by mono- & bi-functionalized triple helix forming oligonucleotides 10.1080/07328319908044831

Optimization of alternate-strand triple helix formation at the 5 '-TpA-3 ' and 5 '-ApT-3 ' junctions 10.1093/nar/27.15.3029

A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus 10.1074/jbc.272.25.16010

Mycobacterium tuberculosis inhibits human innate immune responses via the production of TLR2 antagonist glycolipids 10.1073/pnas.1707840114

ArfGAP1 restricts Mycobacterium tuberculosis entry by controlling the actin cytoskeleton 10.15252/embr.201744371

ArfGAP1 restricts Mycobacterium tuberculosis entry by controlling the actin cytoskeleton 10.15252/embr.201744371 10.15252/embr.201744371.

Combination therapy for tuberculosis treatment: pulmonary administration of ethionamide and booster co-loaded nanoparticles 10.1038/s41598-017-05453-3

Cyclipostins and Cyclophostin analogs as promising compounds in the fight against tuberculosis 10.1038/s41598-017-11843-4 10.1038/s41598-017-11843-4.

Fragment-Sized EthR Inhibitors Exhibit Exceptionally Strong Ethionamide Boosting Effect in Whole-Cell Mycobacterium tuberculosis Assays 10.1021/acschembio.7b00091

Host-pathogen systems for early drug discovery against tuberculosis 10.1016/j.mib.2017.11.017 10.1016/j.mib.2017.11.017.

Legionella pneumophila Modulates Mitochondrial Dynamics to Trigger Metabolic Repurposing of Infected Macrophages 10.1016/j.chom.2017.07.020 10.1016/j.chom.2017.07.020. Epub 2017 Aug 31.

Mycobacterium tuberculosis Controls Phagosomal Acidification by Targeting CISH-Mediated Signaling 10.1016/j.celrep.2017.08.101 10.1016/j.celrep.2017.08.101.

Mycobacterium tuberculosis inhibits human innate immune responses via the production of TLR2 antagonist glycolipids 10.1073/pnas.1707840114 10.1073/pnas.1707840114.

Identification of Piperazinylbenzenesulfonamides as New Inhibitors of Claudin-1 Trafficking and Hepatitis C Virus Entry 10.1128/jvi.01982-17

Multiplexed Quantitation of Intraphagocyte Mycobacterium tuberculosis Secreted Protein Effectors 10.1016/j.celrep.2018.03.125

Oxadiazolone derivatives, new promising multi-target inhibitors against M. tuberculosis 10.1016/j.bioorg.2018.08.025

Proteomics of Mycobacterium infection: Moving towards a Better Understanding of Pathogen-Driven immunomodulation 10.3389/fimmu.2018.00086

Synergy between circular bacteriocin AS-48 and ethambutol against Mycobacterium tuberculosis 10.1128/aac.00359-18

The EU approved antimalarial pyronaridine shows antitubercular activity and synergy with rifampicin, targeting RNA polymerase 10.1016/j.tube.2018.08.004

Cyclipostins and Cyclophostin analogs as promising compounds in the fight against tuberculosis 10.1038/s41598-017-11843-4

Cyclodextrin-based nanocarriers containing a synergic drug combination: A potential formulation for pulmonary administration of antitubercular drugs 10.1016/j.ijpharm.2017.05.030

Host-pathogen systems for early drug discovery against tuberculosis 10.1016/j.mib.2017.11.017

Legionella pneumophila Modulates Mitochondrial Dynamics to Trigger Metabolic Repurposing of Infected Macrophages 10.1016/j.chom.2017.07.020

Mycobacterium tuberculosis Controls Phagosomal Acidification by Targeting CISH-Mediated Signaling 10.1016/j.celrep.2017.08.101

Phenotypic assays for Mycobacterium tuberculosis infection 10.1002/cyto.a.23129

A fast, fully automated cell segmentation algorithm for high-throughput and high-content screening 10.1002/cyto.a.20627

Compartmentalized Encapsulation of Two Antibiotics in Porous Nanoparticles: an Efficient Strategy to Treat Intracellular Infections 10.1002/ppsc.201800360

Spatiotemporal Changes of the Phagosomal Proteome in Dendritic Cells in Response to LPS Stimulation 10.1074/mcp.RA119.001316

Mycolactone as Analgesic: Subcutaneous Bioavailability Parameters 10.3389/fphar.2019.00378

Intrinsic Antibacterial Activity of Nanoparticles Made of β-Cyclodextrins Potentiates Their Effect as Drug Nanocarriers against Tuberculosis 10.1021/acsnano.8b07902

Mitochondrial Dynamics and Activity in Legionella-Infected Cells 10.1007/978-1-4939-9048-1_13

Heparin-Binding Hemagglutinin Adhesin (HBHA) Is Involved in Intracytosolic Lipid Inclusions Formation in Mycobacteria 10.3389/fmicb.2018.02258

Dehydrojuncusol, a Natural Phenanthrene Compound Extracted from Juncus maritimus, Is a New Inhibitor of Hepatitis C Virus RNA Replication 10.1128/jvi.02009-18

A novel codrug made of the combination of ethionamide and its potentiating booster: synthesis, self-assembly into nanoparticles and antimycobacterial evaluation 10.1039/C9OB00680J

Could Mycolactone Inspire New Potent Analgesics? Perspectives and Pitfalls 10.3390/toxins11090516

Paradoxical Roles of the MAL/Tirap Adaptor in Pathologies. 10.3389/fimmu.2020.569127

Fragment-Based Optimized EthR Inhibitors with in Vivo Ethionamide Boosting Activity. 10.1021/acsinfecdis.9b00277

Intracellular and in vivo evaluation of imidazo[2,1-b]thiazole-5-carboxamide anti-tuberculosis compounds. 10.1371/journal.pone.0227224

Preclinical assessment of a new live attenuated Mycobacterium tuberculosis Beijing-based vaccine for tuberculosis. 10.1016/j.vaccine.2019.11.085

IRG1 controls immunometabolic host response and restricts intracellular Mycobacterium tuberculosis infection 10.1101/761551

Worms' Antimicrobial Peptides. 10.3390/md17090512

T(oo)bAd. 10.1038/s41589-019-0347-x

Theaflavins, polyphenols of black tea, inhibit entry of hepatitis C virus in cell culture. 10.1371/journal.pone.0198226

Plant extracts from Cameroonian medicinal plants strongly inhibit hepatitis C virus infection in vitro. 10.3389/fmicb.2015.00488

Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis. 10.1038/nm.3262

Discovery of novel N-phenylphenoxyacetamide derivatives as EthR inhibitors and ethionamide boosters by combining high-throughput screening and synthesis. 10.1021/jm300377g

Shortening the drug discovery pipeline: small molecule high content screening for lead discovery in neglected disease. 10.1186/1753-6561-5-s1-p38

Automated HTS/HCS for antivirals using visual HIV full replication assays. 10.1186/1742-4690-6-s2-p82

Influence of ESAT-6 secretion system 1 (RD1) of Mycobacterium tuberculosis on the interaction between mycobacteria and the host immune system. 10.4049/jimmunol.174.6.3570

Cell microbiology interview 10.1111/cmi.13288

Pathogenomic analyses of Mycobacterium microti, an ESX-1-deleted member of the Mycobacterium tuberculosis complex causing disease in various hosts 10.1099/mgen.0.000505

emmanuel bourinet

bourinet emmanuel

ORCID: 0000-0001-8021-0419

Dissecting the functional role of different isoforms of the L-type Ca 2+ channel 10.1172/JCI200421815

Cyclic AMP-dependent regulation of P-type calcium channels expressed in Xenopus oocytes 10.1007/BF00374391

Determinants of voltage-dependent inactivation affect Mibefradil block of calcium channels 10.1016/S0028-3908(99)00153-7

Cav3.2 calcium channels: The key protagonist in the supraspinal effect of paracetamol 10.1016/j.pain.2014.01.015

TAFA4, a Chemokine-like Protein, Modulates Injury-Induced Mechanical and Chemical Pain Hypersensitivity in Mice 10.1016/j.celrep.2013.09.013

Multiple determinants in voltage-dependent P/Q calcium channels control their retention in the endoplasmic reticulum 10.1046/j.1460-9568.2002.02168.x

The NALCN ion channel is activated by M3 muscarinic receptors in a pancreatic β-cell line 10.1038/embor.2009.125

Regulation by protein kinase-C of putative P-type Ca channels expressed in Xenopus oocytes from cerebellar mRNA 10.1016/0014-5793(93)81504-S

Transcriptional Profiling of Cutaneous MRGPRD Free Nerve Endings and C-LTMRs 10.1016/j.celrep.2015.01.022

Crosstalk between G proteins and protein kinase C mediated by the calcium channel α1 subunit 10.1038/385442a0

T-type calcium channel inhibition underlies the analgesic effects of the endogenous lipoamino acids 10.1523/JNEUROSCI.2919-09.2009

Differential targeting of the L-type Ca2+ channel α1C (Cav1.2) to synaptic and extrasynaptic compartments in hippocampal neurons 10.1111/j.0953-816X.2004.03272.x

Voltage gated calcium channels as targets for analgesics 10.2174/1568026054367610

Amino Acid Residues Outside of the Pore Region Contribute to N-type Calcium Channel Permeation 10.1074/jbc.C000791200

Animal Models of Chemotherapy-Evoked Painful Peripheral Neuropathies 10.1016/j.nurt.2009.07.003

T-type calcium channels contribute to colonic hypersensitivity in a rat model of irritable bowel syndrome 10.1073/pnas.1100869108

Silencing of the Cav3.2 T-type calcium channel gene in sensory neurons demonstrates its major role in nociception 10.1038/sj.emboj.7600515

T-type calcium channels in chronic pain: Mouse models and specific blockers 10.1007/s00424-014-1484-4

Role of the TREK2 potassium channel in cold and warm thermosensation and in pain perception 10.1016/j.pain.2014.09.013

The Deubiquitinating Enzyme USP5 Modulates Neuropathic and Inflammatory Pain by Enhancing Cav3.2 Channel Activity 10.1016/j.neuron.2014.07.036

Electrophysiological characterization of a TTX-sensitive sodium current in native xenopus oocytes 10.1098/rspb.1992.0140

Splicing of α(1A) subunit gene generates phenotypic variants of P- and Q-type calcium channels 10.1038/8070

Voltage-gated calcium channels in chronic pain: Emerging role of alternative splicing 10.1007/s00424-007-0390-4

T-type calcium channels as targets of analgesics: Concept validation | Canaux calciques de type T comme cibles d'antalgiques: Validation du concept 10.1007/s11724-008-0105-4

A destructive interaction mechanism accounts for dominant-negative effects of misfolded mutants of voltage-gated calcium channels 10.1523/JNEUROSCI.2844-07.2008

Calcium currents recorded from a neuronal α1C L-type calcium channel in Xenopus oocytes 10.1016/0014-5793(94)00357-2

Antisense depletion of β-subunits fails to affect T-type calcium channels properties in a neuroblastoma cell line 10.1016/S0028-3908(98)00060-4

Heterodimerization of ORL1 and opioid receptors and its consequences for N-type calcium channel regulation 10.1074/jbc.M109.040634

Functional role of L-type Cav1.3 Ca2+ channels in cardiac pacemaker activity 10.1073/pnas.0935295100

Stable membrane expression of postsynaptic CaV1.2 calcium channel clusters is independent of interactions with AKAP79/150 and PDZ proteins 10.1523/JNEUROSCI.3213-08.2008

Plasma membrane expression of T-type calcium channel α1 subunits is modulated by high voltage-activated auxiliary subunits 10.1074/jbc.M313450200

Nickel block of a family of neuronal calcium channels: Subtype- and subunit-dependent action at multiple sites 10.1007/s002329900059

Specific properties of T-type calcium channels generated by the human α(1I) subunit 10.1074/jbc.C000090200

Agonist-independent modulation of N-type calcium channels by ORL1 receptors 10.1038/nn1180

T-type calcium channels in neuropathic pain 10.1097/j.pain.0000000000000469

T-type calcium channels in pain neuronal circuits 10.1007/978-3-642-40282-1_6

Alleviating pain hypersensitivity through activation of type 4 metabotropic glutamate receptor 10.1523/JNEUROSCI.1221-13.2013

GINIP, a Gαi-Interacting protein, functions as a key modulator of peripheral GABAB receptor-mediated analgesia 10.1016/j.neuron.2014.08.056

Oxaliplatin-induced cold hypersensitivity is due to remodelling of ion channel expression in nociceptors 10.1002/emmm.201100134

Specific contribution of human T-type calcium channel isotypes (α1G, α1H and α1l) to neuronal excitability 10.1113/jphysiol.2001.013269

T-type calcium channel Cav3.2 deficient mice show elevated anxiety, impaired memory and reduced sensitivity to psychostimulants 10.3389/fnbeh.2014.00092

Genetic alteration of the metal/redox modulation of Cav3.2 T-type calcium channel reveals its role in neuronal excitability 10.1113/JP271925

State-dependent properties of a new T-type calcium channel blocker enhance CaV3.2 selectivity and support analgesic effects 10.1016/j.pain.2012.10.023

The Low-Threshold Calcium Channel Cav3.2 Determines Low-Threshold Mechanoreceptor Function 10.1016/j.celrep.2014.12.042

AKAP79 modulation of L-type channels involves disruption of intramolecular interactions in the Cav1.2 subunit 10.4161/chan.20865

Molecular physiology of human cardiovascular ion channels: From electrophysiology to molecular genetics 10.1016/S0076-6879(98)93008-7

Calcium-permeable ion channels in pain signaling 10.1152/physrev.00023.2013

Multiple structural elements contribute to voltage-dependent facilitation of neuronal α1C (CaV1.2) L-type calcium channels 10.1016/S0028-3908(01)00025-9

Endogenous Xenopus-oocyte Ca-channels are regulated by protein kinases A and C 10.1016/0014-5793(92)80087-W

Voltage-dependent calcium channels and cardiac pacemaker activity: From ionic currents to genes 10.1016/j.pbiomolbio.2005.05.003

cAMP-dependent phosphorylation of the cardiac L-type Ca channel: A missing link? 10.1016/0300-9084(95)80008-5

Determinants of the G protein-dependent opioid modulation of neuronal calcium channels 10.1073/pnas.93.4.1486

Molecular and functional properties of the human α(1G) subunit that forms T-type calcium channels 10.1074/jbc.275.9.6090

ORL1 receptor-mediated internalization of N-type calcium channels 10.1038/nn1605

Protein kinase C regulation of cardiac calcium channels expressed in Xenopus oocytes 10.1007/BF00374834

Functional properties of a neuronal class C L-type calcium channel 10.1016/0028-3908(93)90006-O

Fxyd2 regulates Aδ- and C-fiber mechanosensitivity and is required for the maintenance of neuropathic pain 10.1038/srep36407

Block of voltage-gated calcium channels by peptide toxins 10.1016/j.neuropharm.2016.10.016

Role of T-type calcium channels in neuropathic pain | Rôle des canaux calciques de type T dans les douleurs neuropathiques 10.1007/s11724-016-0481-4

A Bacterial Toxin with Analgesic Properties: Hyperpolarization of DRG Neurons by Mycolactone 10.3390/toxins9070227

5-HT2A receptor-dependent phosphorylation of mGlu2 receptor at Serine 843 promotes mGlu2 receptor-operated Gi/o signaling 10.1038/s41380-018-0069-6

TRPV1 regulates opioid analgesia during inflammation 10.1101/274233

TACAN is an essential component of the mechanosensitive ion channel responsible for pain sensing 10.1101/338673

The Low-Threshold Calcium Channel Cav3.2 Mediates Burst Firing of Mature Dentate Granule Cells 10.1093/cercor/bhy084

Assessing the Chemical and Biological Diversity of an Ion Channels Knowledge Database 10.4161/chan.5099

TRPV1 promotes opioid analgesia during inflammation 10.1126/scisignal.aav0711

Evaluation of the Spider (Phlogiellus genus) Phlotoxin 1 and Synthetic Variants as Antinociceptive Drug Candidates 10.3390/toxins11090484

TACAN Is an Ion Channel Involved in Sensing Mechanical Pain 10.1016/j.cell.2020.01.033

Nathalie deboosere

deboosere Nathalie

ORCID: 0000-0002-2873-5485

ArfGAP1 restricts Mycobacterium tuberculosis entry by controlling the actin cytoskeleton. 10.15252/embr.201744371

Mycobacterium tuberculosis Controls Phagosomal Acidification by Targeting CISH-Mediated Signaling. 10.1016/j.celrep.2017.08.101

A Bacterial Toxin with Analgesic Properties: Hyperpolarization of DRG Neurons by Mycolactone. 10.3390/toxins9070227

Phenotypic assays for Mycobacterium tuberculosis infection. 10.1002/cyto.a.23129

Fragment-Sized EthR Inhibitors Exhibit Exceptionally Strong Ethionamide Boosting Effect in Whole-Cell Mycobacterium tuberculosis Assays. 10.1021/acschembio.7b00091

STAT3 Represses Nitric Oxide Synthesis in Human Macrophages upon Mycobacterium tuberculosis Infection. 10.1038/srep29297

LppM impact on the colonization of macrophages by Mycobacterium tuberculosis. 10.1111/cmi.12619

A microscopic phenotypic assay for the quantification of intracellular mycobacteria adapted for high-throughput/high-content screening. 10.3791/51114

Adhesion of human pathogenic enteric viruses and surrogate viruses to inert and vegetal food surfaces. 10.1016/j.fm.2012.04.007

Viral elution and concentration method for detection of influenza A viruses in mud by real-time RT-PCR. 10.1016/j.jviromet.2011.10.013

Comparison of chlorine and peroxyacetic-based disinfectant to inactivate Feline calicivirus, Murine norovirus and Hepatitis A virus on lettuce. 10.1016/j.ijfoodmicro.2011.08.011

Direct detection of highly pathogenic avian influenza A/H5N1 virus from mud specimens. 10.1016/j.jviromet.2011.06.002

Development and validation of a concentration method for the detection of influenza a viruses from large volumes of surface water. 10.1128/aem.02484-10

A predictive microbiology approach for thermal inactivation of Hepatitis A virus in acidified berries. 10.1016/j.fm.2010.05.018

Assessment of the removal and inactivation of influenza viruses H5N1 and H1N1 by drinking water treatment. 10.1016/j.watres.2010.01.013

Intra-laboratory validation of a concentration method adapted for the enumeration of infectious F-specific RNA coliphage, enterovirus, and hepatitis A virus from inoculated leaves of salad vegetables. 10.1016/j.ijfoodmicro.2005.11.007

Modelling effect of physical and chemical parameters on heat inactivation kinetics of hepatitis A virus in a fruit model system. 10.1016/j.ijfoodmicro.2003.10.015

Host-pathogen systems for early drug discovery against tuberculosis. 10.1016/j.mib.2017.11.017

Mycobacterium tuberculosis inhibits human innate immune responses via the production of TLR2 antagonist glycolipids. 10.1073/pnas.1707840114

Cyclipostins and Cyclophostin analogs as promising compounds in the fight against tuberculosis. 10.1038/s41598-017-11843-4

Legionella pneumophila Modulates Mitochondrial Dynamics to Trigger Metabolic Repurposing of Infected Macrophages. 10.1016/j.chom.2017.07.020

Combination therapy for tuberculosis treatment: pulmonary administration of ethionamide and booster co-loaded nanoparticles. 10.1038/s41598-017-05453-3

Host-directed therapies offer novel opportunities for the fight against tuberculosis. 10.1016/j.drudis.2017.05.005

Cyclodextrin-based nanocarriers containing a synergic drug combination: A potential formulation for pulmonary administration of antitubercular drugs. 10.1016/j.ijpharm.2017.05.030

Impact of pe_pgrs33 Gene Polymorphisms on Mycobacterium tuberculosis Infection and Pathogenesis. 10.3389/fcimb.2017.00137

Clofazimine encapsulation in nanoporous silica particles for the oral treatment of antibiotic-resistant Mycobacterium tuberculosis infections. 10.2217/nnm-2016-0364

Reversion of antibiotic resistance in Mycobacterium tuberculosis by spiroisoxazoline SMARt-420. 10.1126/science.aag1006

How can nanoparticles contribute to antituberculosis therapy? 10.1016/j.drudis.2017.01.011

Genome-wide, high-content siRNA screening identifies the Alzheimer's genetic risk factor FERMT2 as a major modulator of APP metabolism. 10.1007/s00401-016-1652-z

Identification of aminopyrimidine-sulfonamides as potent modulators of Wag31-mediated cell elongation in mycobacteria. 10.1111/mmi.13535

Mycobacterium tuberculosis LppM Displays an Original Structure and Domain Composition Linked to a Dual Localization. 10.1016/j.str.2016.07.009

Khaya grandifoliola C.DC: a potential source of active ingredients against hepatitis C virus in vitro. 10.1007/s00705-016-2771-5

[Mycolactone: the amazing analgesic mycobacterial toxin]. 10.1051/medsci/20163202007

A fragment merging approach towards the development of small molecule inhibitors of Mycobacterium tuberculosis EthR for use as ethionamide boosters. 10.1039/c5ob02630j

Polyphenols Inhibit Hepatitis C Virus Entry by a New Mechanism of Action. 10.1128/jvi.01473-15

Plant extracts from Cameroonian medicinal plants strongly inhibit hepatitis C virus infection in vitro. 10.3389/fmicb.2015.00488

Increased protective efficacy of recombinant BCG strains expressing virulence-neutral proteins of the ESX-1 secretion system. 10.1016/j.vaccine.2015.03.083

Cytosolic access of Mycobacterium tuberculosis: critical impact of phagosomal acidification control and demonstration of occurrence in vivo. 10.1371/journal.ppat.1004650

[High content screening in chemical biology: overview and main challenges]. 10.1051/medsci/20153102016

Testing chemical and genetic Modulators in Mycobacterium tuberculosis infected cells using phenotypic assays. 10.1007/978-1-4939-2450-9_24

2-Carboxyquinoxalines kill mycobacterium tuberculosis through noncovalent inhibition of DprE1. 10.1021/cb5007163

High-content screening technology combined with a human granuloma model as a new approach to evaluate the activities of drugs against Mycobacterium tuberculosis. 10.1128/aac.03705-14

Mycobacterial toxin induces analgesia in buruli ulcer by targeting the angiotensin pathways. 10.1016/j.cell.2014.04.040

Ligand efficiency driven design of new inhibitors of Mycobacterium tuberculosis transcriptional repressor EthR using fragment growing, merging, and linking approaches. 10.1021/jm500422b

Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis. 10.1038/nm.3262

The balance of apoptotic and necrotic cell death in Mycobacterium tuberculosis infected macrophages is not dependent on bacterial virulence. 10.1371/journal.pone.0047573

Discovery of novel N-phenylphenoxyacetamide derivatives as EthR inhibitors and ethionamide boosters by combining high-throughput screening and synthesis. 10.1021/jm300377g

Ethionamide boosters. 2. Combining bioisosteric replacement and structure-based drug design to solve pharmacokinetic issues in a series of potent 1,2,4-oxadiazole EthR inhibitors. 10.1021/jm200825u

A novel specific edge effect correction method for RNA interference screenings. 10.1093/bioinformatics/btr648

Analogous mechanisms of resistance to benzothiazinones and dinitrobenzamides in Mycobacterium smegmatis. 10.1371/journal.pone.0026675

High-content screening in infectious diseases. 10.1016/j.cbpa.2011.05.023

Ethionamide boosters: synthesis, biological activity, and structure-activity relationships of a series of 1,2,4-oxadiazole EthR inhibitors. 10.1021/jm200076a

Shortening the drug discovery pipeline: small molecule high content screening for lead discovery in neglected disease. 10.1186/1753-6561-5-s1-p38

High content phenotypic cell-based visual screen identifies Mycobacterium tuberculosis acyltrehalose-containing glycolipids involved in phagosome remodeling. 10.1371/journal.ppat.1001100

High-content imaging of Mycobacterium tuberculosis-infected macrophages: an in vitro model for tuberculosis drug discovery. 10.4155/fmc.10.223

Functional characterization of the Mycobacterium tuberculosis serine/threonine kinase PknJ. 10.1099/mic.0.038133-0

High content screening identifies decaprenyl-phosphoribose 2' epimerase as a target for intracellular antimycobacterial inhibitors. 10.1371/journal.ppat.1000645

Systematic genetic nomenclature for type VII secretion systems. 10.1371/journal.ppat.1000507

Long-circulating DNA lipid nanocapsules as new vector for passive tumor targeting. 10.1016/j.biomaterials.2009.09.044

Automated HTS/HCS for antivirals using visual HIV full replication assays. 10.1186/1742-4690-6-s2-p82

Benzothiazinones kill Mycobacterium tuberculosis by blocking arabinan synthesis. 10.1126/science.1171583

Automated high-throughput siRNA transfection in raw 264.7 macrophages: a case study for optimization procedure. 10.1177/1087057108328762

Control of M. tuberculosis ESAT-6 secretion and specific T cell recognition by PhoP. 10.1371/journal.ppat.0040033

ESAT-6 from Mycobacterium tuberculosis dissociates from its putative chaperone CFP-10 under acidic conditions and exhibits membrane-lysing activity. 10.1128/jb.00469-07

[Aquatic insects and transmission of Mycobacterium ulcerans]. 10.1051/medsci/20072367572

Impact of Mycobacterium ulcerans biofilm on transmissibility to ecological niches and Buruli ulcer pathogenesis. 10.1371/journal.ppat.0030062

Protection against Mycobacterium ulcerans lesion development by exposure to aquatic insect saliva. 10.1371/journal.pmed.0040064

Synthesis and antimycobacterial evaluation of benzofurobenzopyran analogues. 10.1016/j.bmc.2006.12.009

Inactivation of Rv2525c, a substrate of the twin arginine translocation (Tat) system of Mycobacterium tuberculosis, increases beta-lactam susceptibility and virulence. 10.1128/jb.00631-06

High frequency of CD4+ T cells specific for the TB10.4 protein correlates with protection against Mycobacterium tuberculosis infection. 10.1128/iai.02086-05

Benzofuro[3,2-f][1]benzopyrans: a new class of antitubercular agents. 10.1016/j.bmc.2006.03.033

An increase in antimycobacterial Th1-cell responses by prime-boost protocols of immunization does not enhance protection against tuberculosis. 10.1128/iai.74.4.2128-2137.2006

Dissection of ESAT-6 system 1 of Mycobacterium tuberculosis and impact on immunogenicity and virulence. 10.1128/iai.74.1.88-98.2006

Tuberculosis: from genome to vaccine. 10.1586/14760584.4.4.541

Immunogenic membrane-associated proteins of Mycobacterium tuberculosis revealed by proteomics. 10.1099/mic.0.27799-0

Influence of ESAT-6 secretion system 1 (RD1) of Mycobacterium tuberculosis on the interaction between mycobacteria and the host immune system. 10.4049/jimmunol.174.6.3570

Evaluation of vaccines in the EU TB Vaccine Cluster using a guinea pig aerosol infection model of tuberculosis. 10.1016/j.tube.2004.09.009

ESAT-6 proteins: protective antigens and virulence factors? 10.1016/j.tim.2004.09.007

Enhanced protection against tuberculosis by vaccination with recombinant Mycobacterium microti vaccine that induces T cell immunity against region of difference 1 antigens. 10.1086/421468

Cell envelope protein PPE68 contributes to Mycobacterium tuberculosis RD1 immunogenicity independently of a 10-kilodalton culture filtrate protein and ESAT-6. 10.1128/iai.72.4.2170-2176.2004

CD8+-T-cell responses of Mycobacterium-infected mice to a newly identified major histocompatibility complex class I-restricted epitope shared by proteins of the ESAT-6 family. 10.1128/iai.71.12.7173-7177.2003

Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis. 10.1038/nm859

Loss of RD1 contributed to the attenuation of the live tuberculosis vaccines Mycobacterium bovis BCG and Mycobacterium microti. 10.1046/j.1365-2958.2002.03237.x

Bacterial artificial chromosome-based comparative genomic analysis identifies Mycobacterium microti as a natural ESAT-6 deletion mutant. 10.1128/iai.70.10.5568-5578.2002

Disruption of HIV-1 integrase-DNA complexes by short 6-oxocytosine-containing oligonucleotides. 10.1021/bi015732y

IRG1 controls immunometabolic host response and restricts intracellular Mycobacterium tuberculosis infection 10.1101/761551

Large scale screening discovers clofoctol as an inhibitor of SARS-CoV-2 replication that reduces COVID-19-like pathology 10.1101/2021.06.30.450483

Estelle Marion

Marion Estelle

ORCID: 0000-0003-4917-9665

Chitin promotesMycobacterium ulceransgrowth 10.1093/femsec/fiw067

Clinical Features of Spontaneous Partial Healing During Mycobacterium ulcerans Infection 10.1093/ofid/ofw013

FVB/N Mice Spontaneously Heal Ulcerative Lesions Induced by Mycobacterium ulcerans and Switch M. ulcerans into a Low Mycolactone Producer 10.4049/jimmunol.1502194

La mycolactone 10.1051/medsci/20163202007

A Field Study in Benin to Investigate the Role of Mosquitoes and Other Flying Insects in the Ecology of Mycobacterium ulcerans 10.1371/journal.pntd.0003941

Buruli Ulcer in South Western Nigeria: A Retrospective Cohort Study of Patients Treated in Benin 10.1371/journal.pntd.0003443

Development of a Dry-Reagent-Based qPCR to Facilitate the Diagnosis of Mycobacterium ulcerans Infection in Endemic Countries 10.1371/journal.pntd.0003606

Simple, Rapid Mycobacterium ulcerans Disease Diagnosis from Clinical Samples by Fluorescence of Mycolactone on Thin Layer Chromatography 10.1371/journal.pntd.0004247

A case of guilt by association: Water bug bite incriminated in M. ulcerans infection 10.1016/j.ijmyco.2014.01.004

Buruli Ulcer Disease in Republic of the Congo 10.3201/eid2006.131498

Establishment of Quantitative PCR (qPCR) and Culture Laboratory Facilities in a Field Hospital in Benin: 1-Year Results 10.1128/jcm.02131-14

Findings in Patients From Benin With Osteomyelitis and Polymerase Chain Reaction-Confirmed Mycobacterium ulcerans Infection 10.1093/cid/ciu584

First Detection of Mycobacterium ulcerans DNA in Environmental Samples from South America 10.1371/journal.pntd.0002660

Mycobacterial Toxin Induces Analgesia in Buruli Ulcer by Targeting the Angiotensin Pathways 10.1016/j.cell.2014.04.040

Buruli ulcer: a dynamic transversal research model performed through the international network of Pasteur Institutes 10.1051/medsci/20132910021

Parasitic genotypes appear to differ in leishmaniasis patients compared with asymptomatic related carriers 10.1016/j.ijpara.2012.12.008

Regulation of Mycolactone, the Mycobacterium ulcerans Toxin, Depends on Nutrient Source 10.1371/journal.pntd.0002502

Photodegradation of the Mycobacterium ulcerans Toxin, Mycolactones: Considerations for Handling and Storage 10.1371/journal.pone.0033600

Geographic Expansion of Buruli Ulcer Disease, Cameroon 10.3201/eid1703091859

Buruli Ulcer, Central African Republic 10.3201/eid1604.090195

Seasonal and Regional Dynamics of M. ulcerans Transmission in Environmental Context: Deciphering the Role of Water Bugs as Hosts and Vectors 10.1371/journal.pntd.0000731

Use of Fine-Needle Aspiration for Diagnosis of Mycobacterium ulcerans Infection 10.1128/jcm.00558-10

Mycolactone Gene Expression Is Controlled by Strong SigA-Like Promoters with Utility in Studies of Mycobacterium ulcerans and Buruli Ulcer 10.1371/journal.pntd.0000553

Mycolactone toxin induces an inflammatory response by targeting the IL-1β pathway: Mechanistic insight into Buruli ulcer pathophysiology 10.1371/journal.ppat.1009107

High antibody titres induced by protein subunit vaccines using Mycobacterium ulcerans antigens Hsp18 and MUL_3720 with a TLR-2 agonist fail to protect against Buruli ulcer in mice 10.7717/peerj.9659

Genome-wide association study of Buruli ulcer in rural Benin highlights role of two LncRNAs and the autophagy pathway 10.1038/s42003-020-0920-6

Rifampicin and clarithromycin (extended release) versus rifampicin and streptomycin for limited Buruli ulcer lesions: a randomised, open-label, non-inferiority phase 3 trial 10.1016/s0140-6736(20)30047-7

Skin-specific antibodies neutralizing mycolactone toxin during the spontaneous healing of Mycobacterium ulcerans infection 10.1126/sciadv.aax7781

Stable and Local Reservoirs of Mycobacterium ulcerans Inferred from the Nonrandom Distribution of Bacterial Genotypes, Benin 10.3201/eid2603.190573

Vaccine-Specific Immune Responses against Mycobacterium ulcerans Infection in a Low-Dose Murine Challenge Model 10.1128/iai.00753-19

Senegal, a new potential endemic country for Buruli ulcer? 10.1016/j.ijid.2019.09.020

Effect of well drilling on Buruli ulcer incidence in Benin: a case-control, quantitative survey 10.1016/s2542-5196(19)30110-x

Mycolactone as Analgesic: Subcutaneous Bioavailability Parameters 10.3389/fphar.2019.00378

Microdeletion on chromosome 8p23.1 in a familial form of severe Buruli ulcer 10.1371/journal.pntd.0006429

The potent effect of mycolactone on lipid membranes 10.1371/journal.ppat.1006814

A Bacterial Toxin with Analgesic Properties: Hyperpolarization of DRG Neurons by Mycolactone 10.3390/toxins9070227

Mouse model of colonization of the digestive tract withAcinetobacter baumanniiand subsequent pneumonia 10.2217/fmb-2016-0203

Draft Genome Sequence of Mycobacterium ulcerans S4018 Isolated from a Patient with an Active Buruli Ulcer in Benin, Africa 10.1128/genomea.00248-17

An Optimized Method for Extracting Bacterial RNA from Mouse Skin Tissue Colonized by Mycobacterium ulcerans 10.3389/fmicb.2017.00512

Multiple introductions and recent spread of the emerging human pathogen Mycobacterium ulcerans across Africa 10.1093/gbe/evx003

Isabelle Ricard

Ricard Isabelle

ORCID: 0000-0002-2142-6807

ArfGAP1 restricts Mycobacterium tuberculosis entry by controlling the actin cytoskeleton. 10.15252/embr.201744371

A Bacterial Toxin with Analgesic Properties: Hyperpolarization of DRG Neurons by Mycolactone. 10.3390/toxins9070227

Yersinia pestis requires the 2-component regulatory system OmpR-EnvZ to resist innate immunity during the early and late stages of plague. 10.1093/infdis/jiu274

New insights into how Yersinia pestis adapts to its mammalian host during bubonic plague. 10.1371/journal.ppat.1004029

Inheritance of the lysozyme inhibitor Ivy was an important evolutionary step by Yersinia pestis to avoid the host innate immune response. 10.1093/infdis/jit057

Efficacy of ciprofloxacin-gentamicin combination therapy in murine bubonic plague. 10.1371/journal.pone.0052503

Phenotypic analysis of Yersinia pseudotuberculosis 32777 response regulator mutants: new insights into two-component system regulon plasticity in bacteria. 10.1016/j.ijmm.2007.05.005

Double staining of Plasmodium falciparum nucleic acids with hydroethidine and thiazole orange for cell cycle stage analysis by flow cytometry. 10.1002/cyto.a.10110

Screening of Plasmodium falciparum iron superoxide dismutase inhibitors and accuracy of the SOD-assays. 10.1016/j.bmc.2003.09.011

Ultrastructural and molecular characterization of Pneumocystis carinii isolated from a rhesus monkey (Macaca mulatta). 10.1080/mmy.38.1.61.72

Seog Bae Oh

Oh Seog Bae

ORCID: 0000-0001-7975-6895

Eugenol as local anesthetic 10.1007/978-3-642-22144-6_171

A novel carbamoyloxy arylalkanoyl arylpiperazine compound (SKL-NP) inhibits hyperpolarization-activated cyclic nucleotide-gated (HCN) channel currents in rat dorsal root ganglion neurons 10.4196/kjpp.2012.16.4.237

Selectively targeting pain in the trigeminal system 10.1016/j.pain.2010.02.016

Coapplication of lidocaine and the permanently charged sodium channel blocker QX-314 produces a long-lasting nociceptive blockade in rodents 10.1097/ALN.0b013e3181a915e7

Effects of pilocarpine on the secretory acinar cells in human submandibular glands 10.1016/j.lfs.2006.08.006

Acid evoked thermal hyperalgesia involves peripheral P2Y1 receptor mediated TRPV1 phosphorylation in a rodent model of thrombus induced ischemic pain 10.1186/1744-8069-10-2

TRP channels in dental pain 10.2174/1876386301306010031

Functional type I vanilloid receptor expression by substantia gelatinosa neurons of trigeminal subnucleus caudalis in mice 10.1016/j.neulet.2009.01.061

Eugenol inhibits calcium currents in dental afferent neurons 10.1177/154405910508400913

Natural Killer Cells Degenerate Intact Sensory Afferents following Nerve Injury 10.1016/j.cell.2018.12.022

Regulation of calcium currents by chemokines and their receptors 10.1016/S0165-5728(01)00485-4

Group I mGluR regulates the polarity of spike-timing dependent plasticity in substantia gelatinosa neurons 10.1016/j.bbrc.2006.06.134

Inhibition of GluR current in microvilli of sensory neurons via NA⁺ -microdomain coupling among glur, HCN channel, and NA⁺/K⁺ pump 10.3389/fncel.2018.00113

Molecular expression of Mg²⁺ regulator TRPM7 and CNNM4 in rat odontoblasts 10.1016/j.archoralbio.2018.09.011

A distinct functional distribution of α and γ motoneurons in the rat trigeminal motor nucleus 10.1007/s00429-017-1400-8

Eugenol inhibits ATP-induced P2X currents in trigeminal ganglion neurons 10.4196/kjpp.2008.12.6.315

Reduced acute nociception and chronic pain in Shank2^−/− mice 10.1177/1744806916647056

P2X 1 and P2X 4 receptor currents in mouse macrophages 10.1038/sj.bjp.0707504

NKG2D ligation relieves 2B4-mediated NK-cell self-tolerance in mice 10.1002/eji.201343724

Pharmacopuncture With Scolopendra subspinipes Suppresses Mechanical Allodynia in Oxaliplatin-Induced Neuropathic Mice and Potentiates Clonidine-induced Anti-allodynia Without Hypotension or Motor Impairment 10.1016/j.jpain.2018.04.015

Single-cell RT-PCR and immunocytochemical detection of mechanosensitive transient receptor potential channels in acutely isolated rat odontoblasts 10.1016/j.archoralbio.2014.07.016

Hedonic drinking engages a supraspinal inhibition of thermal nociception in adult rats 10.1097/j.pain.0000000000001482

The F-actin-microtubule crosslinker shot is a platform for Krasavietz-mediated translational regulation of midline axon repulsion 10.1242/dev.02842

Cellular and molecular mechanisms of dental nociception 10.1177/0022034513501877

Expression of the Na⁺-HCO3^- cotransporter and its role in pHi regulation in guinea pig salivary glands 10.1152/ajpgi.00483.2005

Electrophysiological and morphological properties of α and γ motoneurons in the rat trigeminal motor nucleus 10.3389/fncel.2018.00009

Necrotic neuronal cells induce inflammatory Schwann cell activation via TLR2 and TLR3: Implication in Wallerian degeneration 10.1016/j.bbrc.2006.09.108

Histamine 1 receptor-Gβγ-cAMP/PKA-CFTR pathway mediates the histamine-induced resetting of the suprachiasmatic circadian clock 10.1186/s13041-016-0227-1

Inhibition of mechanical allodynia in neuropathic pain by TLR5-mediated A-fiber blockade 10.1038/nm.3978

Molecular cloning and functional expression of a sodium bicarbonate cotransporter from guinea-pig parotid glands 10.1016/j.bbrc.2006.02.064

Electrophysiological analysis of neuronal chemokine receptors 10.1016/S1046-2023(02)00357-2

Cytotoxic Immunity in Peripheral Nerve Injury and Pain 10.3389/fnins.2020.00142

Adult rat odontoblasts lack noxious thermal sensitivity 10.1177/0022034509334100

Spinal sigma-1 receptors activate NADPH oxidase 2 leading to the induction of pain hypersensitivity in mice and mechanical allodynia in neuropathic rats 10.1016/j.phrs.2013.05.004

Clonidine, an alpha-2 adrenoceptor agonist relieves mechanical allodynia in oxaliplatin-induced neuropathic mice; Potentiation by spinal p38 MAPK inhibition without motor dysfunction and hypotension 10.1002/ijc.29980

Effects of saccharin intake on hippocampal and cortical plasticity in juvenile and adolescent rats 10.4196/kjpp.2010.14.2.113

CD4 dependence of gp120IIIB-CXCR4 interaction is cell-type specific 10.1016/S0165-5728(03)00162-0

Spinal sigma-1 receptor activation increases the production of d-serine in astrocytes which contributes to the development of mechanical allodynia in a mouse model of neuropathic pain 10.1016/j.phrs.2015.08.019

Substance P Sensitizes P2X3 in nociceptive trigeminal neurons 10.1177/0022034510377094

Permeation and block of TRPV1 channels by the cationic lidocaine derivative QX-314 10.1152/jn.00012.2013

Eugenol inhibits sodium currents in dental afferent neurons 10.1177/154405910608501005

Acute inflammation reveals GABAA receptor-mediated nociception in mouse dorsal root ganglion neurons via PGE2 receptor 4 signaling 10.14814/phy2.13178

GABAergic and serotonergic modulation of calcium currents in rat trigeminal motoneurons 10.1016/S0006-291X(03)01527-4

A critical role of spinal Shank2 proteins in NMDA-induced pain hypersensitivity 10.1177/1744806916688902

Microglial interleukin-1β in the ipsilateral dorsal horn inhibits the development of mirror-image contralateral mechanical allodynia through astrocyte activation in a rat model of inflammatory pain 10.1097/j.pain.0000000000000148

Role of peripheral sigma-1 receptors in ischaemic pain: Potential interactions with ASIC and P2X receptors 10.1002/ejp.774

Sinomenine produces peripheral analgesic effects via inhibition of voltage-gated sodium currents 10.1016/j.neuroscience.2017.06.024

Toll-like receptor 2 contributes to glial cell activation and heme oxygenase-1 expression in traumatic brain injury 10.1016/j.neulet.2007.11.057

TRPM2 contributes to LPC-induced intracellular Ca²⁺ influx and microglial activation 10.1016/j.bbrc.2017.02.087

Sphingosine-1-phosphate signaling in human submandibular cells 10.1177/0022034510376044

Functional epitope of muscarinic type 3 receptor which interacts with autoantibodies from Sjögren's syndrome patients 10.1093/rheumatology/ken064

Generation of resonance-dependent oscillation by mGluR-I activation switches single spiking to bursting in mesencephalic trigeminal sensory neurons 10.1111/ejn.12858

TRPV1 in GABAergic Interneurons Mediates Neuropathic Mechanical Allodynia and Disinhibition of the Nociceptive Circuitry in the Spinal Cord 10.1016/j.neuron.2012.02.039

Trans-activation of TRPV1 by D1R in mouse dorsal root ganglion neurons 10.1016/j.bbrc.2015.08.096

Expression of CaV3.1 T-type Calcium Channels in Acutely Isolated Adult Rat Odontoblasts 10.1016/j.archoralbio.2020.104864

Activity-dependent silencing reveals functionally distinct itch-generating sensory neurons 10.1038/nn.3404

A role of CB1R in inducing-rhythm coordination between the gustatory and gastrointestinal insula 10.1038/srep32529

Pain fiber anesthetic reduces brainstem fos after tooth extraction 10.1177/0022034513505620

Lysophosphatidylcholine increases neutrophil bactericidal activity by enhancement of azurophil granule-phagosome fusion via glycine·GlyRα 2/TRPM2/p38 MAPK signaling (Journal of Immunology (2010) 184, (4401-4413) 10.4049/jimmunol.1090056

σ1 receptors activate astrocytes via p38 MAPK phosphorylation leading to the development of mechanical allodynia in a mouse model of neuropathic pain 10.1111/bph.12893

Role of purinergic receptor in alpha fodrin degradation in par C5 cells 10.1177/0022034509342227

Chemokines and glycoprotein 120 produce pain hypersensitivity by directly exciting primary nociceptive neurons 10.1523/jneurosci.21-14-05027.2001

Oppainful neuron-microglia interactions in the trigeminal sensory system 10.2174/1876386301003010014

Role of TRP channels in pain sensation 10.1007/978-94-007-0265-3_33

CpG oligodeoxynucleotides induce expression of proinflammatory cytokines and chemokines in astrocytes: The role of c-Jun N-terminal kinase in CpG ODN-mediated NF-κB activation 10.1016/j.jneuroim.2004.04.013

R-type calcium channel isoform in rat dorsal root ganglion neurons 10.4196/kjpp.2010.14.1.45

Oxytocin produces thermal analgesia via vasopressin-1a receptor by modulating TRPV1 and potassium conductance in the dorsal root ganglion neurons 10.4196/kjpp.2018.22.2.173

Characterization of dental nociceptive neurons 10.1177/0022034511399906

Molecular mechanism for local anesthetic action of eugenol in the rat trigeminal system 10.1016/j.pain.2009.03.016

Involvement of cannabinoid type 1 receptor in fasting-induced analgesia 10.1177/1744806920969476

High-resolution transcriptome analysis reveals neuropathic pain gene-expression signatures in spinal microglia after nerve injury 10.1097/j.pain.0000000000000470

Piezo2 Expression in Mechanosensitive Dental Primary Afferent Neurons 10.1177/0022034517702342

Abstracts of the 7^th Asian Pain Symposium 10.1177/1744806917753999

Eugenol reverses mechanical allodynia after peripheral nerve injury by inhibiting hyperpolarization-activated cyclic nucleotide-gated (HCN) channels 10.1016/j.pain.2011.05.018

Eugenol inhibits K⁺ currents in trigeminal ganglion neurons 10.1177/154405910708600918

Recent advances in basic research on the trigeminal ganglion 10.1007/s12576-016-0448-1

Molecular mechanisms underlying calcium current modulation by nociceptin 10.1097/00001756-200410050-00012

Expression of Na⁺/HCO3^- cotransporter and its role in pH regulation in mouse parotid acinar cells 10.1016/S0006-291X(03)00632-6

Activation of microglial P2Y12 receptor is required for outward potassium currents in response to neuronal injury 10.1016/j.neuroscience.2016.01.008

Extracellular ATP Induces Calcium Signaling in Odontoblasts 10.1177/0022034516671308

TRPM7 Mediates Mechanosensitivity in Adult Rat Odontoblasts 10.1177/0022034518759947

Directed induction of functional motor neuron-like cells from genetically engineered human mesenchymal stem cells 10.1371/journal.pone.0035244

Differential Changes in TRPV1 Expression After Trigeminal Sensory Nerve Injury 10.1016/j.jpain.2007.11.013

Activation of vanilloid receptor 1 (VR1) by Eugenol 10.1177/154405910308201004

A bacterial toxin with analgesic properties: Hyperpolarization of DRG neurons by mycolactone 10.3390/toxins9070227

Activation of transient receptor potential ankyrin 1 by eugenol 10.1016/j.neuroscience.2013.12.047

The analgesic effect of refeeding on acute and chronic inflammatory pain 10.1038/s41598-019-53149-7

Desipramine inhibits Na⁺/H⁺ exchanger in human submandibular cells 10.1177/154405910608500912

Activation of glia and microglial p38 MAPK in medullary dorsal horn contributes to tactile hypersensitivity following trigeminal sensory nerve injury 10.1016/j.pain.2005.12.023

Rat odontoblasts may use glutamate to signal dentin injury 10.1016/j.neuroscience.2016.08.029

Attenuation of natural killer cell functions by capsaicin through a direct and TRPV1-independent mechanism: Capsaicin-induced NK cell dysfunction 10.1093/carcin/bgu091

Direct activation of Transient Receptor Potential Vanilloid 1(TRPV1) by Diacylglycerol (DAG) 10.1186/1744-8069-4-42

Peripheral GABA A receptor-mediated signaling facilitates persistent inflammatory hypersensitivity 10.1016/j.neuropharm.2018.04.009

Inhibitory effects of autoantibodies on the muscarinic receptors in Sjögren's syndrome 10.1038/labinvest.3700173

Modulation of CaV2.3 calcium channel currents by eugenol 10.1177/154405910808700201

The status of voltage-dependent calcium channels in α(1E) knock-out mice 10.1523/jneurosci.20-23-08566.2000

TRPM8 Mediates Hyperosmotic Stimuli-Induced Nociception in Dental Afferents 10.1177/0022034519886847

Curcumin produces an antihyperalgesic effect via antagonism of TRPV1 10.1177/0022034509356169

TLR3-mediated signal induces proinflammatory cytokine and chemokine gene expression in astrocytes: Differential signaling mechanisms of TLR3-induced IP-10 and IL-8 gene expression 10.1002/glia.20278

Lysophosphatidylcholine increases neutrophil bactericidal activity by enhancement of azurophil granule-phagosome fusion via glycine-GlyRα2/ TRPM2/p38 MAPK signaling 10.4049/jimmunol.0902814

Effects of somatostatin on the responses of rostrally projecting spinal dorsal horn neurons to noxious stimuli in cats 10.4196/kjpp.2008.12.5.253

Alpha 2 adrenoceptor agonist guanabenz directly inhibits hyperpolarization-activated, cyclic nucleotide-modulated (HCN) channels in mesencephalic trigeminal nucleus neurons 10.1016/j.ejphar.2019.04.036

Erratum: Systemic administration of minocycline inhibits formalin-induced inflammatory pain in rat (Brain Research (2006) 1072 (208-214)) 10.1016/j.brainres.2012.05.003

Systemic administration of minocycline inhibits formalin-induced inflammatory pain in rat 10.1016/j.brainres.2005.12.039

Effect of nitric oxide on hyperpolarization-activated current in substantia gelatinosa neurons of rats 10.1016/j.bbrc.2005.10.129

Oscillation and synchronization in the insular cortex 10.26226/morressier.5b31ec372afeeb0013459fe8

Lack of correlation between spinal microgliosis and long-term development of tactile hypersensitivity in two different sciatic nerve crush injury 10.1177/17448069211011326

Marsollier Laurent

Laurent Marsollier

ORCID: 0000-0001-5497-5995

High antibody titres induced by protein subunit vaccines using Mycobacterium ulcerans antigens Hsp18 and MUL_3720 with a TLR-2 agonist fail to protect against Buruli ulcer in mice. 10.7717/peerj.9659

Genome-wide association study of Buruli ulcer in rural Benin highlights role of two LncRNAs and the autophagy pathway. 10.1038/s42003-020-0920-6

Vaccine-Specific Immune Responses against Mycobacterium ulcerans Infection in a Low-Dose Murine Challenge Model. 10.1128/iai.00753-19

Senegal, a new potential endemic country for Buruli ulcer? 10.1016/j.ijid.2019.09.020

Could Mycolactone Inspire New Potent Analgesics? Perspectives and Pitfalls. 10.3390/toxins11090516

Mycolactone as Analgesic: Subcutaneous Bioavailability Parameters. 10.3389/fphar.2019.00378

Microdeletion on chromosome 8p23.1 in a familial form of severe Buruli ulcer. 10.1371/journal.pntd.0006429

The potent effect of mycolactone on lipid membranes. 10.1371/journal.ppat.1006814

ArfGAP1 restricts Mycobacterium tuberculosis entry by controlling the actin cytoskeleton. 10.15252/embr.201744371

A Bacterial Toxin with Analgesic Properties: Hyperpolarization of DRG Neurons by Mycolactone. 10.3390/toxins9070227

Mouse model of colonization of the digestive tract with Acinetobacter baumannii and subsequent pneumonia. 10.2217/fmb-2016-0203

Ecology and Feeding Habits Drive Infection of Water Bugs with Mycobacterium ulcerans. 10.1007/s10393-017-1228-y

Draft Genome Sequence of Mycobacterium ulcerans S4018 Isolated from a Patient with an Active Buruli Ulcer in Benin, Africa. 10.1128/genomea.00248-17

An Optimized Method for Extracting Bacterial RNA from Mouse Skin Tissue Colonized by Mycobacterium ulcerans. 10.3389/fmicb.2017.00512

Multiple Introductions and Recent Spread of the Emerging Human Pathogen Mycobacterium ulcerans across Africa. 10.1093/gbe/evx003

Deforestation-driven food-web collapse linked to emerging tropical infectious disease, Mycobacterium ulcerans. 10.1126/sciadv.1600387

Chitin promotes Mycobacterium ulcerans growth. 10.1093/femsec/fiw067

Molecular Species Delimitation and Morphology of Aquatic and Sub-Aquatic Bugs (Heteroptera) in Cameroon. 10.1371/journal.pone.0154905

FVB/N Mice Spontaneously Heal Ulcerative Lesions Induced by Mycobacterium ulcerans and Switch M. ulcerans into a Low Mycolactone Producer. 10.4049/jimmunol.1502194

[Mycolactone: the amazing analgesic mycobacterial toxin]. 10.1051/medsci/20163202007

Clinical Features of Spontaneous Partial Healing During Mycobacterium ulcerans Infection. 10.1093/ofid/ofw013

Seasonal Patterns of Buruli Ulcer Incidence, Central Africa, 2002-2012. 10.3201/eid2108.141336

Mycobacterium ulcerans dynamics in aquatic ecosystems are driven by a complex interplay of abiotic and biotic factors. 10.7554/elife.07616

Development of a dry-reagent-based qPCR to facilitate the diagnosis of Mycobacterium ulcerans infection in endemic countries. 10.1371/journal.pntd.0003606

Extrahuman epidemiology of Acinetobacter baumannii in Lebanon. 10.1128/aem.03824-14

Mycobacterium ulcerans disease (Buruli ulcer) in Mali: A new potential African endemic country. 10.2340/00015555-1942

Buruli ulcer in South Western Nigeria: a retrospective cohort study of patients treated in Benin. 10.1371/journal.pntd.0003443

[Detection of the IS2404 insertion sequence and ketoreductase produced by Mycobacterium ulcerans in the aquatic Heteroptera in the health districts of Dabou and Tiassalé in Côte d'Ivoire]. 10.1684/mst.2014.0363

Topography and land cover of watersheds predicts the distribution of the environmental pathogen Mycobacterium ulcerans in aquatic insects. 10.1371/journal.pntd.0003298

Defining and targeting high-risk populations in Buruli ulcer--authors' reply. 10.1016/s2214-109x(14)70312-2

Buruli ulcer acquired in Mali: a rare and atypical situation. 10.1016/j.tmaid.2014.09.009

Findings in patients from Benin with osteomyelitis and polymerase chain reaction-confirmed Mycobacterium ulcerans infection. 10.1093/cid/ciu584

HIV infection and Buruli ulcer in Africa. 10.1016/s1473-3099(14)70882-5

Clinical epidemiology of laboratory-confirmed Buruli ulcer in Benin: a cohort study. 10.1016/s2214-109x(14)70223-2

Mycobacterial toxin induces analgesia in buruli ulcer by targeting the angiotensin pathways. 10.1016/j.cell.2014.04.040

A case of guilt by association: Water bug bite incriminated in M. ulcerans infection. 10.1016/j.ijmyco.2014.01.004

Buruli ulcer disease in Republic of the Congo. 10.3201/eid2006.131498

Mycobacterium ulcerans ecological dynamics and its association with freshwater ecosystems and aquatic communities: results from a 12-month environmental survey in Cameroon. 10.1371/journal.pntd.0002879

First detection of Mycobacterium ulcerans DNA in environmental samples from South America. 10.1371/journal.pntd.0002660

[Buruli ulcer: a dynamic transversal research model performed through the international network of Pasteur Institutes]. 10.1051/medsci/20132910021

Photodegradation of the Mycobacterium ulcerans toxin, mycolactones: considerations for handling and storage. 10.1371/journal.pone.0033600

Adequate wound care and use of bed nets as protective factors against Buruli Ulcer: results from a case control study in Cameroon. 10.1371/journal.pntd.0001392

Geographic expansion of Buruli ulcer disease, Cameroon. 10.3201/eid1703.091859

Oral treatment for Mycobacterium ulcerans infection: results from a pilot study in Benin. 10.1093/cid/ciq072

Serological evaluation of Mycobacterium ulcerans antigens identified by comparative genomics. 10.1371/journal.pntd.0000872

Use of fine-needle aspiration for diagnosis of Mycobacterium ulcerans infection. 10.1128/jcm.00558-10

Buruli ulcer, Central African Republic. 10.3201/eid1604.090195

Mycolactone gene expression is controlled by strong SigA-like promoters with utility in studies of Mycobacterium ulcerans and buruli ulcer. 10.1371/journal.pntd.0000553

High content screening identifies decaprenyl-phosphoribose 2' epimerase as a target for intracellular antimycobacterial inhibitors. 10.1371/journal.ppat.1000645

Buruli ulcer in long-term traveler to Senegal. 10.3201/eid1501.080123

Optimized method for preparation of DNA from pathogenic and environmental mycobacteria. 10.1128/aem.01358-08

Characterization of active site structure in CYP121. A cytochrome P450 essential for viability of Mycobacterium tuberculosis H37Rv. 10.1074/jbc.m802115200

Comprehensive proteome analysis of Mycobacterium ulcerans and quantitative comparison of mycolactone biosynthesis. 10.1002/pmic.200701018

Risk factors for buruli ulcer: a case control study in Cameroon. 10.1371/journal.pntd.0000101

[Aquatic insects and transmission of Mycobacterium ulcerans]. 10.1051/medsci/20072367572

Impact of Mycobacterium ulcerans biofilm on transmissibility to ecological niches and Buruli ulcer pathogenesis. 10.1371/journal.ppat.0030062

Protection against Mycobacterium ulcerans lesion development by exposure to aquatic insect saliva. 10.1371/journal.pmed.0040064

Early trafficking events of Mycobacterium ulcerans within Naucoris cimicoides. 10.1111/j.1462-5822.2006.00790.x

Inactivation of Rv2525c, a substrate of the twin arginine translocation (Tat) system of Mycobacterium tuberculosis, increases beta-lactam susceptibility and virulence. 10.1128/jb.00631-06

Immunogenicity of Mycobacterium ulcerans Hsp65 and protective efficacy of a Mycobacterium leprae Hsp65-based DNA vaccine against Buruli ulcer. 10.1016/j.micinf.2006.03.009

Dissection of ESAT-6 system 1 of Mycobacterium tuberculosis and impact on immunogenicity and virulence. 10.1128/iai.74.1.88-98.2006

Modulation of the host immune response by a transient intracellular stage of Mycobacterium ulcerans: the contribution of endogenous mycolactone toxin. 10.1111/j.1462-5822.2005.00546.x

Colonization of the salivary glands of Naucoris cimicoides by Mycobacterium ulcerans requires host plasmatocytes and a macrolide toxin, mycolactone. 10.1111/j.1462-5822.2005.00521.x

[Diagnosis of Mycobacterium ulcerans infections in French Guiana]. 10.1016/s0755-4982(04)98974-9

Aquatic snails, passive hosts of Mycobacterium ulcerans. 10.1128/aem.70.10.6296-6298.2004

Aquatic plants stimulate the growth of and biofilm formation by Mycobacterium ulcerans in axenic culture and harbor these bacteria in the environment. 10.1128/aem.70.2.1097-1103.2004

Susceptibility of Mycobacterium ulcerans to a combination of amikacin/rifampicin. 10.1016/s0924-8579(03)00240-1

[Ecology and transmission of Mycobacterium ulcerans]. 10.1016/s0369-8114(03)00151-2

Isolation of three Mycobacterium ulcerans strains resistant to rifampin after experimental chemotherapy of mice. 10.1128/aac.47.4.1228-1232.2003

Aquatic insects as a vector for Mycobacterium ulcerans. 10.1128/aem.68.9.4623-4628.2002